Featured Research

from universities, journals, and other organizations

Powerful new defibrillator: Minimally invasive surgeries mean smaller scars, quicker recovery

Date:
December 26, 2010
Source:
St. Michael's Hospital
Summary:
St. Michael's Hospital has become the first in Ontario to implant a small but powerful new defibrillator into a patient's chest. The defibrillator – about the size of a Zippo lighter – is the smallest available in terms of surface area and can deliver the highest level of energy, 40 joules.

St. Michael's Hospital has become the first in Ontario to implant a small but powerful new defibrillator into a patient's chest.

The defibrillator -- about the size of a Zippo lighter -- is the smallest available in terms of surface area and can deliver the highest level of energy, 40 joules.

The narrow shape of the device allowed Dr. Iqwal Mangat to make a smaller incision in the patient's chest, which should mean a faster recovery and smaller scar. The "minimally invasive" procedure is performed on an outpatient basis, with most patients going home the same day. The small size also means less patient discomfort and less obvious signs of the device under the patient's skin.

The high-energy capability of this device is especially important for patients who have an enlarged weak heart, advanced heart failure or have previously required a high amount of energy to shock their heart back to a normal rhythm.. This device is also coupled with an additional lead on the left side of the heart that allows the heart to "resynchronize," potentially allowing patients to feel more energy and less short of breath.

"The more energy there is in a device to shock a patient, the more likely it is their life will be saved by that device," said Dr. Mangat, director of the hospital's arrhythmia services. "Most people don't need a lot of energy, but sometimes they do."

The new Unify CRT-D defibrillator is made by St. Jude Medical, Inc., based in St. Paul, MN.

St. Michael's implants about 290 defibrillators and 230 pacemakers a year.

What is the difference between a pacemaker and an implanted defibrillator?

A pacemaker is about one-quarter the size of a defibrillator. It monitors your heart rhythm -- which slows with age and certain medications -- and sends electrical pulses to your heart if it is beating too slow or you miss a heartbeat.

A defibrillator is a small, battery-powered device that treats a dangerous fast heart rhythm by delivering a jolt of electricity to the heart. They are typically implanted in patients who have or are at risk for developing ventricular tachycardia or ventricular fibrillation, two types of very fast and life-threatening heart rhythms that originate from the ventricles, the lower chambers of the heart.


Story Source:

The above story is based on materials provided by St. Michael's Hospital. Note: Materials may be edited for content and length.


Cite This Page:

St. Michael's Hospital. "Powerful new defibrillator: Minimally invasive surgeries mean smaller scars, quicker recovery." ScienceDaily. ScienceDaily, 26 December 2010. <www.sciencedaily.com/releases/2010/12/101221172256.htm>.
St. Michael's Hospital. (2010, December 26). Powerful new defibrillator: Minimally invasive surgeries mean smaller scars, quicker recovery. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/12/101221172256.htm
St. Michael's Hospital. "Powerful new defibrillator: Minimally invasive surgeries mean smaller scars, quicker recovery." ScienceDaily. www.sciencedaily.com/releases/2010/12/101221172256.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins